HCA Healthcare, Inc.
HCA · Healthcare · · USDFahodi Score SELL Long-term (Investment)
44
/ 100
Technical
75
Trend & RS
75
Momentum
83
Fundamental
33
Macro
24
Liquidity
40
| Component | Score | Weight |
|---|---|---|
| Technical | 75.0 | 10% |
| Trend & RS | 75.1 | 10% |
| Momentum | 83.1 | 5% |
| Fundamental | 33.3 | 40% |
| Macro | 23.8 | 15% |
| Liquidity | 40.1 | 20% |
Trade Setup
| Entry | 498.69 |
| Stop Loss | 464.52 (6.8%) |
| Target 1 (1:1) | 532.85 (+6.8%) |
| Target 2 (2:1) | 567.00 (+13.7%) |
| ATR(14) | 17.08 (3.4%) |
| Risk per Share | 34.16 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 74.7 | +0.99 | |
| Momentum | 83.1 | +1.33 | |
| Quality | 23.2 | -1.07 | |
| Composite | 60.3 | ||
Quality Scores
Piotroski F-Score
3
/9 —
Weak
✓
✗
✗
✗
✗
✗
✓
✓
✗
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
Insufficient Data
Valuation vs Peers Undervalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | 16.4 | 22.0 | -26% below |
| P/B Ratio | -12.9 | 4.0 | Inline |
| Dividend Yield | 61.0% | 1.5% | Above avg |
Comparing against Healthcare median multiples.
Trading at a discount to sector peers — potential value opportunity.
Intrinsic Value (DCF) Overvalued
Intrinsic Value
398.84
vs
Market Price
494.31
Upside
-19.3%
| Margin of Safety | -23.9% |
| Stage 1 PV (5yr FCF) | 21,686,552,304 |
| Terminal Value PV | 61,627,838,607 |
| Total Enterprise Value | 83,314,390,911 |
Assumptions
| Base FCF | 5,038,486,978 |
| Growth Rate (5yr) | 3.6% |
| Terminal Growth | 2.5% |
| Discount Rate (WACC) | 9.0% |
2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
28.04%
Full Kelly
14.02%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 44/100. Estimated win rate 53%, avg win 7.6%, avg loss 4.1%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary STRONG BUY
3
Bullish Signals
1
Bearish Signals
63.95
RSI(14)
14.5106
MACD
Relative Strength (RS) IMPROVING
62
/ 99
RS Rating
O'Neil filter: <80
| RS vs SPY | ↑ RISING (+25.6% vs SPY 3M) |
| RS vs Sector | OUTPERFORMING (Healthcare) |
| RS New High | ✓ RS at 3-month high Institutional accumulation signal |
| Sector Outperformance | +7.8% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
IMPROVING:
Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 63.95 | NEUTRAL |
| Macd | 14.5106 | BULLISH |
| Ma Cross | 443.5 / 443.62 | DEATH CROSS |
| Trend Short | ABOVE SMA50 | |
| Trend Long | ABOVE SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 0.02x | LOW |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 556.52 |
| Bollinger Upper | 503.59 |
| SMA(200) | 443.62 |
| SMA(50) | 443.5 |
| SMA(20) | 470.53 |
| Current Price | 494.31 |
| Bollinger Lower | 437.48 |
| 52-Week Low | 353.99 |
| ATR(14) | 17.08 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
MARKUP
Confidence
47%
Buying Climax
Sign of Strength
Selling Climax
Acc: 2.0 |
Dist: 2.0 |
Markup: 3.5 |
Markdown: 0.0
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-11-02 | Normal | 1.0x | Normal bar — no special VSA pattern |
| 2026-11-03 | Normal | 0.71x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 2.47x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 1.19x | Normal bar — no special VSA pattern |
| 2026-11-06 | No Supply | 0.02x | Low volume, narrow spread, firm close — no selling pressure |
Ichimoku Cloud BULLISH
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 480.65 | Above Kijun |
| Kijun-sen (26) | 472.86 | Base line |
| Senkou A | 476.75 | Leading span A |
| Senkou B | 458.38 | Leading span B |
| Cloud | 458.38 – 476.75 | Bullish (Green) |
| Price vs Cloud | 498.69 | Above Cloud |
| Chikou Span | 426.69 | Bullish |
| Alignment Score | 4/4 | BULLISH |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE OFF
No squeeze
Momentum:
BULLISH FADING
BB: 437.48 – 503.59 | KC: 445.04 – 496.03
Divergences (last 60 bars)
No significant divergences detected in the last 60 bars.
Anchored VWAP
VWAP: 424.36
Anchor: 2026-07-14 (52w Low)
ABOVE AVWAP
+17.5%
Heikin-Ashi Trend
BULLISH
Full data via /api/advanced/HCA
Valuation
| Metric | Value |
|---|---|
| Market Cap | 103.26B |
| P/E (TTM) | 16.40 |
| Forward P/E | N/A |
| P/B | -12.91 |
| EPS | 30.15 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 3.6% |
| Profit Margin | 8.6% |
| ROE | N/A |
| Debt/Equity | N/A |
| Current Ratio | 0.82 |
| Dividend Yield | 61.0% |
| Payout Ratio | N/A |
| Beta | 1.10 |
Trading Data
494.31
Open
494.31
Day High
494.31
Day Low
90.5K
Volume (0.1x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)